ArticleDiabetologia2022

HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants.

Jamie L Felton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.